Cargando…

Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis

Aims: Reports of hepatitis in children during the coronavirus disease 2019 (COVID-19) pandemic garnered worldwide attention. The most probable culprits are adenovirus and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). At present, the optimal symptomatic treatment consists of a combina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Yanhua, Zhang, Lingling, Wang, Zhe, Wang, Ruoyu, Liang, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403136/ https://www.ncbi.nlm.nih.gov/pubmed/36034788 http://dx.doi.org/10.3389/fphar.2022.969709

Ejemplares similares

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss
por: Wang, Jia, et al.
Publicado: (2020)

Network Pharmacology-Based Strategy to Identify the Pharmacological Mechanisms of Pulsatilla Decoction against Crohn’s Disease
por: Liu, Jinguo, et al.
Publicado: (2022)

Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis
por: Li, Zhiman, et al.
Publicado: (2021)

Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation
por: Cao, Hui, et al.
Publicado: (2018)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
por: Li, Meng, et al.
Publicado: (2022)

The Protecting Effect of Deoxyschisandrin and Schisandrin B on HaCaT Cells against UVB-Induced Damage
por: Hou, Wei, et al.
Publicado: (2015)

Schisandrin alleviates the cognitive impairment in rats with Alzheimer’s disease by altering the gut microbiota composition to modulate the levels of endogenous metabolites in the plasma, brain, and feces
por: Zhang, Chengqin, et al.
Publicado: (2022)

Protective Effects and Network Analysis of Ginsenoside Rb1 Against Cerebral Ischemia Injury: A Pharmacological Review
por: Xie, Weijie, et al.
Publicado: (2021)

Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
por: Shi, Hongwei, et al.
Publicado: (2021)

Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis
por: An, Lin, et al.
Publicado: (2021)

Diosgenin From Dioscorea Nipponica Rhizoma Against Graves’ Disease—On Network Pharmacology and Experimental Evaluation
por: Xin, Jingxin, et al.
Publicado: (2022)

Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice
por: Cui, Binbin, et al.
Publicado: (2022)

Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
por: Zhou, Shanshan, et al.
Publicado: (2020)

Wuzi Yanzong Pill—Based on Network Pharmacology and In Vivo Evidence—Protects Against Spermatogenesis Disorder via the Regulation of the Apoptosis Pathway
por: Chen, Wang-qiang, et al.
Publicado: (2020)

Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
por: Shi, Hongwei, et al.
Publicado: (2021)

Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
por: Yang, Yingying, et al.
Publicado: (2021)

A molecular network-based pharmacological study on the protective effect of Panax notoginseng rhizomes against renal ischemia–reperfusion injury
por: Li, Dan-Dan, et al.
Publicado: (2023)

Corrigendum: Wuzi Yanzong pill—Based on network pharmacology and In Vivo evidence—Protects against spermatogenesis disorder via the regulation of the apoptosis pathway
por: Chen, Wang-qiang, et al.
Publicado: (2023)

Pharmacological Benefits of Triphala: A Perspective for Allergic Rhinitis
por: Jantrapirom, Salinee, et al.
Publicado: (2021)

Schisandrin A Inhibits the IL-1β-Induced Inflammation and Cartilage Degradation via Suppression of MAPK and NF-κB Signal Pathways in Rat Chondrocytes
por: Tu, Chang, et al.
Publicado: (2019)

Mechanisms of resveratrol against diabetic wound by network pharmacology and experimental validation
por: Youjun, Ding, et al.
Publicado: (2023)

Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology
por: Luo, Wen, et al.
Publicado: (2021)

Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022
por: Grasa, Laura, et al.
Publicado: (2022)

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
por: Liu, Minglu, et al.
Publicado: (2022)

Schisandrin A protects against isoproterenol-induced chronic heart failure via miR-155
por: Gao, Lijing, et al.
Publicado: (2022)

Schisandrin Protects against Norepinephrine-Induced Myocardial Hypertrophic Injury by Inhibiting the JAK2/STAT3 Signaling Pathway
por: Yang, Min, et al.
Publicado: (2021)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments
por: Wang, Xuan, et al.
Publicado: (2022)

Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease
por: Wei, Xiaoyi, et al.
Publicado: (2021)

Integrated Network Pharmacology and GC-MS–Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression
por: Li, Yao, et al.
Publicado: (2021)

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
por: Liu, Minglu, et al.
Publicado: (2023)

The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
por: Wang, Yanzhe, et al.
Publicado: (2023)

Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer’s disease
por: Zhao, Tian-tian, et al.
Publicado: (2023)

Antiproliferative and apoptosis-inducing activity of schisandrin B against human glioma cells
por: Li, Qun, et al.
Publicado: (2015)

Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
por: Weiskirchen, Ralf, et al.
Publicado: (2022)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021)

Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo
por: Lam, Ho Yin Pekkle, et al.
Publicado: (2021)

Schisandrin B for the treatment of male infertility
por: Zou, Di‐Xin, et al.
Publicado: (2021)

Network Pharmacology and Molecular Docking to Elucidate the Potential Mechanism of Ligusticum Chuanxiong Against Osteoarthritis
por: Xiang, Cheng, et al.
Publicado: (2022)

Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation
por: Jia, Li-ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kr6pdkl28dqusmd6lbdv2j1fev